EP300 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.592000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.816200E-01
Normal-vs-Stage2
3.766200E-01
Normal-vs-Stage3
1.438030E-01
Normal-vs-Stage4
8.773000E-01
Stage1-vs-Stage2
5.230200E-01
Stage1-vs-Stage3
2.611900E-02
Stage1-vs-Stage4
6.025800E-01
Stage2-vs-Stage3
4.754900E-04
Stage2-vs-Stage4
4.932800E-01
Stage3-vs-Stage4
1.906820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.215800E-01
Normal-vs-AfricanAmerican
9.968600E-01
Normal-vs-Asian
3.836400E-01
Caucasian-vs-AfricanAmerican
1.699170E-01
Caucasian-vs-Asian
7.077800E-01
AfricanAmerican-vs-Asian
2.700800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.896400E-01
Normal-vs-Female
4.526800E-01
Male-vs-Female
4.518600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.278200E-01
Normal-vs-Age(41-60Yrs)
6.336400E-01
Normal-vs-Age(61-80Yrs)
2.792200E-01
Normal-vs-Age(81-100Yrs)
1.771400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.332800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.396400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.232800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.525700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.573800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.189990E-01
Normal-vs-Daily Drinker
8.588000E-02
Normal-vs-Weekly Drinker
3.682200E-01
Normal-vs-Occasional Drinker
4.206000E-01
Normal-vs-Social Drinker
7.065400E-01
Non Drinker-vs-Daily Drinker
5.162200E-01
Non Drinker-vs-Weekly Drinker
4.529400E-01
Non Drinker-vs-Occasional Drinker
1.564220E-01
Non Drinker-vs-Social Drinker
7.060200E-02
Daily Drinker-vs-Weekly Drinker
2.443200E-01
Daily Drinker-vs-Occasional Drinker
6.705700E-02
Daily Drinker-vs-Social Drinker
3.730500E-02
Weekly Drinker-vs-Occasional Drinker
6.670600E-01
Weekly Drinker-vs-Social Drinker
4.123400E-01
Occasional Drinker-vs-Social Drinker
5.944600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.479200E-01
Normal-vs-Grade 2
3.629900E-02
Normal-vs-Grade 3
5.247700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.531400E-01
Grade 1-vs-Grade 3
1.915200E-01
Grade 1-vs-Grade 4
1.479200E-01
Grade 2-vs-Grade 3
4.035600E-01
Grade 2-vs-Grade 4
3.629900E-02
Grade 3-vs-Grade 4
5.247700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.126800E-01
Normal-vs-NonDiabetic
2.127800E-01
Diabetic-vs-NonDiabetic
6.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.168400E-01
Normal-vs-NoPancreatitis
2.362000E-01
Pancreatitis-vs-NoPancreatitis
6.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.763400E-01
Normal-vs-N1
3.769000E-01
N0-vs-N1
5.124800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.644000E-01
Normal-vs-TP53-NonMutant
5.729400E-01
TP53-Mutant-vs-TP53-NonMutant
7.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
